• Bookbook – grāmatas tikai angļu valodā!
Ar kodu EXTRA50,66 cena tikai
56,29 €
How To Control The Tuberculosis And HIV/AIDS Dual Epidemic
How To Control The Tuberculosis And HIV/AIDS Dual Epidemic
50,66 €
56,29 €
  • Mēs nosūtīsim 10-14 darba dienu laikā.
TB patients can be offered an HIV test; indeed , research shows that TB patients are more likely to accept HIV testing than the general population. This means that TB programmes can make a major contribution to identifying eligible candidates for ARV treatment. Many people , including those living with HIV, do not know that TB is curable. This is a basic message and one thing that is failing to get through. We should know how to get the message to policy- makers and funders that more drugs are…
50.66 2025-06-02 08:00:00
  • Extra -10% atlaide, ievadot kodu: EXTRA6d.23:52:24

How To Control The Tuberculosis And HIV/AIDS Dual Epidemic + bezmaksas piegāde! | Bookbook.lv

Atsauksmes

Apraksts

TB patients can be offered an HIV test; indeed , research shows that TB patients are more likely to accept HIV testing than the general population. This means that TB programmes can make a major contribution to identifying eligible candidates for ARV treatment. Many people , including those living with HIV, do not know that TB is curable. This is a basic message and one thing that is failing to get through. We should know how to get the message to policy- makers and funders that more drugs are needed for both diseases. It is not ¿either/or¿, there is no point providing ARVs only for patients to die of TB for lack of TB resources. Similarly , TB efforts alone are insufficient. HIV/AIDS is dramatically fuelling the TB epidemic in sub-Saharan Africa, where up to 70% of TB patients are co-infected with HIV in some countries. For many years efforts to tackle TB and HIV have been largely separate, despite the overlapping epidemiology. Improved collaboration between TB and HIV/AIDS programmes will lead to more effective control of TB among HIV- infected people and to significant public health gains.

10 EXTRA % atlaide

50,66 €
56,29 €
Mēs nosūtīsim 10-14 darba dienu laikā.

Kupona kods: EXTRA

Akcija beidzas 6d.23:52:24

Atlaides kods derīgs pirkumiem no 10 €. Atlaides nav kumulatīvas.

Derīgs tikai pirkumiem tiešsaistē.

Piesakieties, lai
un par šo preci jūs saņemsiet 0,56 Grāmatu eiro!?

TB patients can be offered an HIV test; indeed , research shows that TB patients are more likely to accept HIV testing than the general population. This means that TB programmes can make a major contribution to identifying eligible candidates for ARV treatment. Many people , including those living with HIV, do not know that TB is curable. This is a basic message and one thing that is failing to get through. We should know how to get the message to policy- makers and funders that more drugs are needed for both diseases. It is not ¿either/or¿, there is no point providing ARVs only for patients to die of TB for lack of TB resources. Similarly , TB efforts alone are insufficient. HIV/AIDS is dramatically fuelling the TB epidemic in sub-Saharan Africa, where up to 70% of TB patients are co-infected with HIV in some countries. For many years efforts to tackle TB and HIV have been largely separate, despite the overlapping epidemiology. Improved collaboration between TB and HIV/AIDS programmes will lead to more effective control of TB among HIV- infected people and to significant public health gains.

Atsauksmes

  • Nav atsauksmju
0 klienti novērtēja šo produktu.
5
0%
4
0%
3
0%
2
0%
1
0%